OVAT — Ovation Science Income Statement
0.000.00%
Last trade - 00:00- CA$1.59m
- CA$1.86m
- CA$0.11m
Annual income statement for Ovation Science, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.75 | 0.225 | 0.138 | 0.062 | 0.113 |
| Cost of Revenue | |||||
| Gross Profit | 0.521 | 0.183 | 0.135 | 0.054 | 0.086 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.89 | 2.64 | 0.927 | 0.748 | 0.585 |
| Operating Profit | -1.14 | -2.41 | -0.789 | -0.686 | -0.472 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.18 | -2.39 | -0.794 | -0.813 | -0.456 |
| Net Income After Taxes | -1.18 | -2.39 | -0.794 | -0.813 | -0.456 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.18 | -2.39 | -0.794 | -0.813 | -0.456 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.18 | -2.39 | -0.794 | -0.813 | -0.456 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.042 | -0.028 | -0.027 | -0.027 | -0.013 |